← All trials
NCT02091219
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2014
- Primary completion
- Jun 1, 2017
- Completion date
- Dec 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 35
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of California, Los AngelesLead sponsor
- University of California, Los AngelesOverall official - principal investigator
- University of California, Los AngelesReponsible party - principal investigator
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.